Conceptio
›
Archive
›
ClinicalTrials.gov
ClinicalTrials.gov
public full text
Semaglutide 2.4 mg in Patients With Poor Weight-loss
University College, London
· 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
diabetes
metabolicsyndrome
obesity
semaglutide
obesity, diabetes, metabolic syndrome, semaglutide, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia
#995650
Cryoablation With Pembrolizumab Or Avelumab In Urothelial Carcinoma
#995651
Sacituzumab Govitecan Plus EV in Metastatic UC
#995652
Effects of Multimodal Exercises Integrated With Cognitive-behavioral Therapy in Subjects With Chronic Neck Pain
#995653
Efficacy and Safety Study of SyB L-0501 for Patients With Multiple Myeloma
#995654
Record
· ID 807282
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.